Related Experiment Video
Updated: Dec 8, 2025

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
LATS1-Beclin1 mediates a non-canonical connection between the Hippo pathway and autophagy
Fengyuan Tang1, Gerhard Christofori1
1Department of Biomedicine, University of Basel, Basel, Switzerland.
Abstract:
Understanding the mechanisms of evasive resistance in cancer is of great importance to develop efficient therapies. Analyzing the molecular mechanisms underlying therapy resistance of hepatocellular carcinoma (HCC), we have discovered a kinase-activity independent role of LATS1 (large tumor suppressor) but not LATS2 in regulating sorafenib-induced lethal autophagy in HCC. We have found that the autophagy regulatory role of LATS1 is a general phenomenon in response to various stimuli of autophagy induction which relies on a LATS1-specific protein domain. Mechanistically, the autophagy regulatory role of LATS1 is coupled with Beclin-1 (BECN1) K27-linked ubiquitination and BECN1 self-dimerization. Our study highlights a LATS1-mediated non-classical interaction between the Hippo signaling pathway and autophagy in therapy response and carcinogenesis.
Insights
Large tumor suppressor 1 (LATS1) regulates sorafenib-induced autophagy in liver cancer, independent of kinase activity. This finding reveals a new mechanism in cancer therapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Cellular Biology
Background:
- Therapy resistance is a major challenge in treating hepatocellular carcinoma (HCC).
- Understanding evasive resistance mechanisms is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the molecular mechanisms of sorafenib resistance in HCC.
- To identify the role of LATS1 and LATS2 in regulating autophagy in HCC.
Main Methods:
- Analysis of molecular mechanisms of therapy resistance in HCC.
- Investigated the role of LATS1 and LATS2 in sorafenib-induced autophagy.
- Examined LATS1's interaction with Beclin-1 (BECN1) ubiquitination and self-dimerization.
Main Results:
- Discovered a kinase-activity independent role for LATS1, but not LATS2, in regulating sorafenib-induced lethal autophagy in HCC.
- LATS1's autophagy regulatory role is general across various autophagy stimuli and depends on a specific LATS1 domain.
- LATS1 regulates autophagy via BECN1 K27-linked ubiquitination and BECN1 self-dimerization.
Conclusions:
- LATS1 plays a critical role in regulating autophagy and therapy response in HCC.
- Highlights a novel, non-classical interaction between the Hippo signaling pathway and autophagy in cancer.
- Provides potential therapeutic targets for overcoming sorafenib resistance in HCC.
More Related Videos
Related Concept Videos
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Hedgehog Signaling Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway

